Literature DB >> 17328877

Dipeptidyl peptidase II (DPPII), a review.

Marie-Berthe Maes1, Simon Scharpé, Ingrid De Meester.   

Abstract

An increasing number of biological processes appear to be regulated by Pro-specific N-terminal processing. The proline-specific dipeptidyl peptidases (DPPs) like DPPIV, fibroblast activation protein alpha (FAP), DPPII, DPP8 and DPP9, because of their preference for cleavage after X-Pro in vitro, are likely to be involved in many of these processes. These DPPs are emerging as an important protease family with roles in the regulation of signaling by peptide hormones. Dipeptidyl peptidase II (DPPII, E.C. 3.4.14.2) is an intracellular protease that localizes to the vesicular system. It releases, preferably at acidic pH, N-terminal dipeptides from oligopeptides with Pro or Ala in the penultimate position. Despite the fact that the physiological role of DPPII still has not been elucidated, several suggestions were made on possible functions of the enzyme depending on its localization in different cells, body fluids and organs. DPPII was a.o. suggested to be involved in the processes of cell differentiation and in the protection from cell death, and to have a role in the degradation of collagen fragments, myofibrillar proteins and short neuropeptides. Moreover, changes in the level and distribution of the enzyme provided clues indicating additional roles in disease-related processes. Here we review the DPPII literature, aiming to bring more clarity in the disperse data on this subject and give a state of the art on DPPII research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328877     DOI: 10.1016/j.cca.2007.01.024

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

1.  Random transposon mutagenesis of the Saccharopolyspora erythraea genome reveals additional genes influencing erythromycin biosynthesis.

Authors:  Andrij Fedashchin; William H Cernota; Melissa C Gonzalez; Benjamin I Leach; Noelle Kwan; Roy K Wesley; J Mark Weber
Journal:  FEMS Microbiol Lett       Date:  2015-10-13       Impact factor: 2.742

2.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  High Serum Stability of Collagen Hybridizing Peptides and Their Fluorophore Conjugates.

Authors:  Lucas L Bennink; Daniel J Smith; Catherine A Foss; Martin G Pomper; Yang Li; S Michael Yu
Journal:  Mol Pharm       Date:  2017-05-08       Impact factor: 4.939

4.  Proteomic study of activated Taenia solium oncospheres.

Authors:  S J Santivañez; A Hernández-González; N Chile; A Oleaga; Y Arana; S Palma; M Verastegui; A E Gonzalez; R Gilman; H H Garcia; M Siles-Lucas
Journal:  Mol Biochem Parasitol       Date:  2010-02-06       Impact factor: 1.759

Review 5.  More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling.

Authors:  Shreyasi Gupta; Utpal Sen
Journal:  Pharmacol Res       Date:  2019-08-08       Impact factor: 7.658

6.  Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.

Authors:  E Fröhlich; E Engel; R Wahl
Journal:  Horm Metab Res       Date:  2011-03-16       Impact factor: 2.936

7.  Proline-rich cytokine from neurosecretory granules: a new natural substrate for dipeptidyl peptidase IV.

Authors:  Alvard A Antonyan; Svetlana G Sharoyan; Sona S Mardanyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2010-09-14       Impact factor: 3.996

8.  Enzyme activity and immunohistochemical localization of dipeptidyl peptidase 8 and 9 in male reproductive tissues.

Authors:  Véronique Dubois; Chris Van Ginneken; Hilde De Cock; Anne-Marie Lambeir; Pieter Van der Veken; Koen Augustyns; Xin Chen; Simon Scharpé; Ingrid De Meester
Journal:  J Histochem Cytochem       Date:  2009-02-02       Impact factor: 2.479

9.  Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome.

Authors:  Chi-Bun Chan; Michiyo Abe; Noriyoshi Hashimoto; Chunhai Hao; Ifor R Williams; Xia Liu; Shinji Nakao; Akitsugu Yamamoto; Chengyun Zheng; Jan-Inge Henter; Marie Meeths; Magnus Nordenskjold; Shi-Yong Li; Ikuko Hara-Nishimura; Masahide Asano; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

Review 10.  Weighing the evidence for a ternary protein complex mediating A-type K+ currents in neurons.

Authors:  Jonathon Maffie; Bernardo Rudy
Journal:  J Physiol       Date:  2008-10-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.